Adding cetuximab to paclitaxel and carboplatin for first-line treatment of carcinoma of unknown primary (CUP): results of the Phase 2 AIO trial PACET-CUP.
Gunnar FolprechtKarolin TrautmannAlexander SteinGerdt HuebnerMichael StahlStefan KasperAlbrecht KretzschmarClaus-Henning KöhneViktor GruenwaldRalf-Dieter HofheinzKatharina SchütteHarald LöfflerCarsten BokemeyerAlwin Krämernull nullPublished in: British journal of cancer (2020)
The study was registered at clinicaltrials.gov as NCT00894569.